Dynamic Technology Lab’s GSK GSK Stock Holding History

Dynamic Technology Lab’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-38,071	Closed	-$1.47M	–	1137
2024 Q2	$1.47M	Buy	+38,071	New	+$1.6M	0.17%	208
2023 Q1	–	Sell	-22,526	Closed	-$792K	–	1267
2022 Q4	$792K	Buy	+22,526	New	+$750K	0.08%	418
2021 Q4	–	Sell	-5,872	Closed	-$280K	–	1268
2021 Q3	$280K	Buy	+5,872	New	+$295K	0.03%	783
2017 Q3	–	Sell	-5,384	Closed	-$290K	–	1172
2017 Q2	$290K	Buy	+5,384	New	+$287K	0.05%	717
2017 Q1	–	Sell	-8,342	Closed	-$402K	–	1070
2016 Q4	$402K	Buy	+8,342	New	+$412K	0.11%	363
2016 Q1	–	Sell	-4,755	Closed	-$240K	–	1018
2015 Q4	$240K	Buy	+4,755	New	+$242K	0.07%	617
2013 Q4	–	Sell	-7,156	Closed	-$449K	–	595
2013 Q3	$449K	Buy	+7,156	New	+$461K	0.36%	46

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's GSK Position: Q3 2024 in Review

Dynamic Technology Lab sold out of GSK (GSK) in Q3 2024, closing a stake of 38,071 shares — an estimated $1.47M sold.

Dynamic Technology Lab first reported a position in GSK in Q3 2013 and held it in 7 quarters. The position peaked at $1.47M in Q2 2024. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Dynamic Technology Lab reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
Dynamic Technology Lab sold 38,071 GSK shares in Q3 2024, an estimated $1.47M.
Dynamic Technology Lab first reported a position in GSK in Q3 2013 and held it in 7 quarters.
Dynamic Technology Lab's GSK position peaked at $1.47M in Q2 2024.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.